Cidara Therapeutics Inc.

NASDAQ: CDTX · Real-Time Price · USD
65.38
1.83 (2.88%)
At close: Aug 15, 2025, 3:59 PM
66.25
1.33%
After-hours: Aug 15, 2025, 06:59 PM EDT

Cidara Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-169.83M -22.93M -29.8M -42.47M
Depreciation & Amortization
233K 118K 1.23M -1.23M
Stock-Based Compensation
3.91M 3.06M 3.53M 4.01M
Other Working Capital
-33.3M 3.7M 3.3M 8.62M
Other Non-Cash Items
3.09M 1.24M 1K 15K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-13.93M -3.92M -3.43M 14.44M
Operating Cash Flow
-176.53M -22.43M -28.47M -25.23M
Capital Expenditures
-129K -505K -118K -41K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-129K -505K -118K -41K
Debt Repayment
-276K n/a -2.59M -4.44M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
7K 21K -720K 6K
Financial Cash Flow
337.06M 25.98M -951K 44.6M
Net Cash Flow
160.4M 3.05M -29.54M 19.32M
Free Cash Flow
-176.66M -22.94M -28.59M -25.27M